Scynexis Inc (SCYX) stock news · rev $20.6M
Scynexis Inc (SCYX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This SCYX news page leads with what Scynexis Inc filed — not a scraped headline mill.
No cached 8-K sentence for SCYX yet. We will not pad this page with generic market recap.
Latest reported SCYX revenue for 2025-12-31 was $20.6M. Net income was -$8.6M. Revenue was up 449.9% from 2024-12-31 to 2025-12-31. SCYX currently screens at market cap $37.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SCYX stock page; for the tape open the quote page.
SCYX stock news FAQ
What are SCYX's latest revenue and net income?
Latest cached Scynexis Inc (SCYX) revenue for Dec 31, 2025 was $20.6M. Net income was -$8.6M. Statements: https://lician.com/financials/scyx
How did SCYX revenue change from the prior cached period?
Cached Scynexis Inc (SCYX) revenue was up 449.9% from $3.7M (Dec 31, 2024) to $20.6M (Dec 31, 2025). Statements: https://lician.com/financials/scyx
What is SCYX's market cap?
Scynexis Inc (SCYX) market cap is $37.7M on the latest cached fundamentals snapshot.
What kind of company is SCYX?
Scynexis Inc (SCYX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Where is SCYX stock news listed?
Cached stock news for Scynexis Inc (SCYX) is listed at https://lician.com/news/scyx. Filings: https://lician.com/sec/scyx
Not investment advice.